Total Payments
$114,464
2024 Payments
$46,724
Companies
56
Transactions
1,174
Medicare Patients
6,043
Medicare Billing
$757,375
Payment Breakdown by Category
Other$38,200 (33.4%)
Food & Beverage$31,856 (27.8%)
Consulting$30,969 (27.1%)
Research$6,827 (6.0%)
Travel$6,148 (5.4%)
Education$465.21 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $31,856 | 1,113 | 27.8% |
| Consulting Fee | $30,969 | 13 | 27.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $26,750 | 9 | 23.4% |
| Compensation for serving as faculty or as a speaker for a medical education program | $7,650 | 2 | 6.7% |
| Unspecified | $6,827 | 3 | 6.0% |
| Travel and Lodging | $6,148 | 19 | 5.4% |
| Honoraria | $3,800 | 6 | 3.3% |
| Education | $465.21 | 9 | 0.4% |
Payments by Type
General
$107,638
1,171 transactions
Research
$6,827
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $35,915 | 115 | $0 (2024) |
| ConvaTec Inc. | $23,523 | 31 | $0 (2024) |
| TRIAD LIFE SCIENCES INC. | $13,046 | 26 | $0 (2022) |
| Eli Lilly and Company | $6,827 | 3 | $0 (2024) |
| MAYNE PHARMA INC. | $4,106 | 54 | $0 (2022) |
| ABBVIE INC. | $3,953 | 123 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $3,134 | 54 | $0 (2024) |
| Dermavant Sciences, Inc. | $2,239 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,124 | 69 | $0 (2024) |
| PFIZER INC. | $2,113 | 107 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $46,724 | 202 | Galderma Laboratories, L.P. ($18,022) |
| 2023 | $28,076 | 151 | Galderma Laboratories, L.P. ($15,971) |
| 2022 | $16,298 | 153 | TRIAD LIFE SCIENCES INC. ($13,046) |
| 2021 | $3,174 | 123 | AbbVie Inc. ($746.35) |
| 2020 | $4,950 | 95 | MAYNE PHARMA INC. ($3,155) |
| 2019 | $4,702 | 145 | Biofrontera Inc. ($499.06) |
| 2018 | $5,970 | 156 | Ortho Dermatologics, a division of Bausch Health US, LLC ($2,454) |
| 2017 | $4,570 | 149 | Aqua Pharmaceuticals ($837.08) |
All Payment Transactions
1,174 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Immunology | ||||||
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: Immunology | ||||||
| 12/11/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Inflammation & Immunology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.28 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/06/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $22.00 | General |
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $74.16 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: DERMATOLOGY | ||||||
| 12/02/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $38.74 | General |
| Category: Immunology | ||||||
| 11/27/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: Dermatology | ||||||
| 11/25/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Inflammation & Immunology | ||||||
| 11/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $7.70 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $21.60 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $5.50 | General |
| 11/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $0.96 | General |
| Category: Dermatology | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $76.72 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, 52 WEEK STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY3454738 IN THE TREATMENT OF ADULT PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS | Eli Lilly and Company | $3,500 | 1 |
| A STUDY OF LY3454738 IN THE TREATMENT OF ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS | Eli Lilly and Company | $3,222 | 1 |
| EFFICACY AND SAFETY OF IXEKIZUMAB OR IXEKIZUMAB CONCOMITANTLY ADMINISTERED WITH TIRZEPATIDE IN ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS AND OBESITY OR OVERWEIGHT: A PHASE 3B, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY (TOGETHER-PSO) | Eli Lilly and Company | $104.58 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,895 | 12,580 | $620,223 | $263,168 |
| 2022 | 22 | 1,579 | 3,550 | $462,817 | $195,282 |
| 2021 | 16 | 1,395 | 3,002 | $397,979 | $175,618 |
| 2020 | 18 | 1,174 | 2,442 | $306,994 | $123,306 |
Total Patients
6,043
Total Services
21,574
Medicare Billing
$757,375
Procedure Codes
81
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 338 | 776 | $115,861 | $49,771 | 43.0% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 13 | 2,028 | $50,117 | $24,671 | 49.2% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 85 | 6,800 | $47,192 | $23,135 | 49.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 188 | 255 | $47,831 | $21,060 | 44.0% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 35 | 42 | $47,311 | $18,647 | 39.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 133 | 190 | $40,158 | $17,769 | 44.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 176 | 245 | $41,210 | $15,887 | 38.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 240 | 406 | $45,227 | $15,719 | 34.8% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 41 | 46 | $32,679 | $15,435 | 47.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 117 | 117 | $21,980 | $8,714 | 39.6% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 24 | 28 | $22,125 | $7,906 | 35.7% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 16 | 22 | $14,983 | $7,377 | 49.2% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 20 | 23 | $15,309 | $6,852 | 44.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 170 | 1,158 | $12,525 | $5,765 | 46.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $9,170 | $4,063 | 44.3% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 29 | 35 | $14,296 | $3,507 | 24.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 49 | 78 | $7,351 | $3,355 | 45.6% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 41 | 74 | $7,037 | $2,628 | 37.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 39 | 55 | $4,593 | $2,253 | 49.1% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 16 | 17 | $7,962 | $1,954 | 24.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 13 | $3,879 | $1,755 | 45.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $3,764 | $1,703 | 45.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 12 | 14 | $3,951 | $1,609 | 40.7% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 13 | 17 | $3,549 | $1,554 | 43.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 42 | 95 | $165.88 | $78.75 | 47.5% |
About Dr. Jerome Obed, DO
Dr. Jerome Obed, DO is a Dermatology healthcare provider based in Fort Lauderdale, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720055585.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jerome Obed, DO has received a total of $114,464 in payments from pharmaceutical and medical device companies, with $46,724 received in 2024. These payments were reported across 1,174 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($31,856).
As a Medicare-enrolled provider, Obed has provided services to 6,043 Medicare beneficiaries, totaling 21,574 services with total Medicare billing of $757,375. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Fort Lauderdale, FL
- Active Since 03/01/2006
- Last Updated 08/20/2016
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720055585
Products in Payments
- INNOVAMATRIX AC (Device) $36,459
- AKLIEF (Drug) $7,979
- VTAMA (Drug) $2,239
- ONEXTON (Drug) $2,063
- FABIOR (Drug) $1,800
- DUPIXENT (Biological) $1,594
- COSENTYX (Biological) $1,344
- SORILUX (Drug) $1,200
- TREMFYA (Drug) $1,168
- AMELUZ (Drug) $1,140
- EUCRISA (Drug) $1,134
- SKYRIZI (Biological) $1,085
- Otezla (Drug) $1,060
- TALTZ (Drug) $1,050
- DORYX (Drug) $1,043
- CIBINQO (Drug) $979.06
- RINVOQ (Biological) $751.54
- Humira (Biological) $668.27
- Sotyktu (Drug) $567.79
- COSENTYX (Drug) $540.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Fort Lauderdale
Dr. Luis Soro, D.o, D.O
Dermatology — Payments: $354,229
Dermatology $354,229
Matthew Elias, D.o, D.O
Dermatology — Payments: $203,852
Dermatology $203,852
Jason Green, Do, DO
Dermatology — Payments: $139,763
Dermatology $139,763
Khongruk Wongkittiroch, D.o, D.O
Dermatology — Payments: $30,301
Dermatology $30,301
Dr. Merrick Elias, D.o, D.O
Dermatology — Payments: $23,530
Dermatology $23,530
Sasha Chediak, D.o, D.O
Dermatology — Payments: $8,810
Dermatology $8,810